China Precision Steel, Inc. (NASDAQ:CPSL) announced that on May 15th 2014, the Company received a delisting notice from NASDAQ Stock Market, LLC due to the failure to pay certain fees required by Listing Rule 5250(f). The Company elects not to appeal. China Precision Steel, Inc. (NASDAQ:CPSL) weekly performance is -16.85%. On last trading day company shares ended up $1.53. Analysts mean target price for the company is $2.00. China Precision Steel, Inc. (NASDAQ:CPSL) distance from 50-day simple moving average (SMA50) is -31.73%.
China Commercial Credit, Inc. (NASDAQ:CCCR), a microfinance company providing financial services to small-to-medium enterprises (SMEs), farmers and individuals in Jiangsu Province, reported that, for the three months ended March 31, 2014, the company reported net income of $1,093,633, or $.10 per share, on revenue of $2,054,009. This compares with net income of $1,569,868, or $.17 per share, on revenue of $2,670,253 in the like year-ago quarter. Total weighted average shares outstanding were 10,434,862 in the first quarter of 2014 versus 9,000,000 in the first quarter of 2013. China Commercial Credit Inc (NASDAQ:CCCR) shares advanced 3.07% in last trading session and ended the day on $3.77. CCCR return on assets is 7.30%. China Commercial Credit Inc (NASDAQ:CCCR) quarterly performance is -41.24%.
RiceBran Technologies (NASDAQ:RIBT) generated $35 million in revenue in 2013, though it wasn’t profitable on the basis of earnings before interest, taxes, depreciation and amortization, or EBITDA, a widely-followed metric. The 2014 forecast is for 69% revenue growth and $2 EBITDA per share. Company has approximately 3 million shares outstanding and a market capitalization of approximately $19 million. RiceBran Technologies (NASDAQ:RIBT) shares moved up 7.53% in last trading session and was closed at $7.00, while trading in range of $6.56 – $7.18. RiceBran Technologies (NASDAQ:RIBT) year to date (YTD) performance is 40.28%.
Dehaier Medical Systems Ltd. (NASDAQ:DHRM), an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, on 30 April 2014 announced it has become the authorized agent of Olympus (Beijing) Sales & Service Co., Ltd. (“Olympus”) to supply its electronic gastroscope and electronic bronchoscope products to participate in several medical device procurement projects funded by the Chinese government. Pursuant to the authorization letter with Olympus, the company will be responsible for bidding, agreement negotiation and execution of the projects. Dehaier Medical Systems Ltd (NASDAQ:DHRM) ended the last trading day at $6.67. Company weekly volatility is calculated as 11.42% and price to cash ratio as 7.36. Dehaier Medical Systems Ltd (NASDAQ:DHRM) showed a positive weekly performance of 38.38%.
S&P has five of the six Puerto Rico banks it rates on negative watch or on negative outlook, while Fitch has a negative outlook on one of its four banks, Doral Financial Corp. (NYSE:DRL). Fitch has lower ratings than S&P on three of the four banks both agencies rate. Doral Financial Corp. (NYSE:DRL) net profit margin is -27.20% and weekly performance is -14.04%. On last trading day company shares ended up $2.51. Doral Financial Corp. (NYSE:DRL) distance from 50-day simple moving average (SMA50) is -68.43%.